CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K Reporting owner sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-21 | Blanks Robert | Sale | −4,855 | $7.81 | $38K | 362,331 |
| 2024-05-14 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −3,000 | $7.99 | $24K | 1,307,933 |
| 2024-05-06 | Felsch Robert Ora | Exercise or conversion | +79,101 | $0.84 | $66K | 263,935 |
| 2024-05-06 | Felsch Robert Ora | Exercise or conversion | +40,000 | $2.75 | $110K | 303,935 |
| 2024-05-06 | Felsch Robert Ora | Sale | −152,988 | $8.81 | $1.3M | 150,947 |
| 2024-05-06 | Felsch Robert Ora | Sale | −55,000 | $8.80 | $484K | 95,947 |
| 2024-05-06 | Felsch Robert Ora | Exercise or conversion · Stock Option (Right to Buy) | −79,101 | 61,525 | ||
| 2024-05-06 | Felsch Robert Ora | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 80,000 | ||
| 2024-05-06 | GRAMMER ELIZABETH A | Exercise or conversion | +110,250 | $0.99 | $109K | 378,243 |
| 2024-05-06 | GRAMMER ELIZABETH A | Exercise or conversion | +109,687 | $2.75 | $302K | 487,930 |
| 2024-05-06 | GRAMMER ELIZABETH A | Sale | −64,233 | $8.87 | $570K | 423,697 |
| 2024-05-06 | GRAMMER ELIZABETH A | Sale | −219,937 | $8.88 | $2.0M | 203,760 |
| 2024-05-06 | GRAMMER ELIZABETH A | Exercise or conversion · Stock Option (Right to Buy) | −110,250 | 85,750 | ||
| 2024-05-06 | GRAMMER ELIZABETH A | Exercise or conversion · Stock Option (Right to Buy) | −109,687 | 241,313 | ||
| 2024-05-03 | GRAMMER ELIZABETH A | Sale 10b5-1 | −45,000 | $9.00 | $405K | 267,993 |
| 2024-05-03 | Williams Laura A Chief Medical Officer | Exercise or conversion 10b5-1 | +30,000 | $0.99 | $30K | 410,138 |
| 2024-05-03 | Williams Laura A Chief Medical Officer | Sale 10b5-1 | −39,949 | $8.35 | $334K | 370,189 |
| 2024-05-03 | Williams Laura A Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −30,000 | 162,000 | ||
| 2024-04-29 | RAAB MICHAEL President & CEO | Exercise or conversion 10b5-1 | +30,000 | $0.99 | $30K | 1,340,933 |
| 2024-04-29 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −30,000 | $6.40 | $192K | 1,310,933 |
Page 15 of 18 · 360 trades